RiverVest Funds I, II & III RiverVest Fund IV Archer Seed Fund

14 Dec

Posted at 13:37h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Houston, TXIDEV Technologies, Inc. developed the Supera™ stent for the treatment of peripheral artery disease. The use of interwoven, individual, flexible nitinol wires enables a unique combination of high compression resistance, low chronic outward...

13 Dec

Posted at 21:23h in by

/ PORTFOLIO San Diego, CALumena was co-founded by RiverVest in 2010 to develop oral therapeutic compounds for the treatment of rare cholestatic liver diseases. The company’s lead asset, LUM001, was a novel, once-daily, orally administered, potent and selective apical sodium-dependent bile acid transporter (ASBT) inhibitor that...

13 Dec

Posted at 21:20h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Minneapolis, MNFounded in part by RiverVest, Lutonix developed the first FDA-approved drug-coated angioplasty balloon catheter that delivers paclitaxel to the arterial wall when used for the treatment of peripheral artery disease. Paclitaxel is an...

13 Dec

Posted at 21:17h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Rockville, MDIPO October 2013 (NASDAQ: MGNX)MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of...

13 Dec

Posted at 21:13h in by

/ PORTFOLIO San Francisco, CAIPO July 2019 (NASDAQ: MIRM)Mirum was formed in 2018, with support from RiverVest, to advance maralixibat, an ASBT inhibitor previously developed by Lumena Pharmaceuticals, a RiverVest Fund II company. Mirum went public in July 2019, and RiverVest liquidated its position in the...

13 Dec

Posted at 21:09h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} San Diego, CAMpex Pharmaceuticals developed inhaled levofloxacin (brand name Quinsair), an antibiotic used for long-term lung infection treatment in people with cystic fibrosis. Levofloxacin is a well-known antibiotic that had been approved and prescribed...

13 Dec

Posted at 21:06h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} San Diego, CAOtonomy works to bring new treatment options to patients with hearing and balance disorders. Otonomy’s technology enables drugs to reach targets effectively and safely within the protected inner ear. The company is...

13 Dec

Posted at 21:03h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Portsmouth, NHSalient Surgical developed the AquamantysTM system, which uses proprietary TranscollationTM technology that combines radiofrequency (RF) energy and saline to provide sealing of vascular tissue without the smoke and charring associated with competing methods....

13 Dec

Posted at 20:58h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Cleveland, OHSecurus Medical developed a device to provide clinicians a simple to use, real-time, noncontact, thermal map of body cavity tissue temperature, including in the esophagus during ablation procedures for treating atrial fibrillation, to...

13 Dec

Posted at 20:55h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Minneapolis, MNVelocimed developed multiple unique interventional cardiology products, including a proximal embolic protection device (Proxis™), a patent foramen ovale (“PFO”) closure device (PremereTM) and a directional catheter (VentureTM) for navigating tortuous vasculature. Each of...

13 Dec

Posted at 20:53h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Fort Worth, TXIPO June 2014, then acquired by AstraZeneca December 2015.ZS Pharma developed Lokelma, a drug to treat hyperkalemia, a serious condition characterized by elevated potassium levels in the blood associated with cardiovascular, renal...

13 Dec

Posted at 20:50h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Portland, ORSparrow Pharmaceuticals was founded to spare patients the ravages of corticosteroids. Leveraging underappreciated scientific insights into steroid biology, the company is working to provide better treatment options for serious disorders of hypercortisolism, and...

13 Dec

Posted at 20:48h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} San Carlos, CAGlycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes,...

13 Dec

Posted at 20:45h in by

/ PORTFOLIO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} Waltham, MASeQure Dx, Inc. is applying state-of-the-art genomics technologies for gene editor target profiling to advance discovery, clinical development, and diagnostic solutions. Their core technologies, GUIDE-seq and ONE-seq, enable identification of all potential off-target...

13 Dec

Posted at 20:41h in by

/ PORTFOLIO San Francisco, CABluejay Therapeutics, founded in 2021, was developing brelovitug, a fully human monoclonal antibody with Breakthrough Therapy and PRIME designations for chronic hepatitis delta virus (HDV). At the time of acquisition by Mirum Pharmaceuticals, brelovitug was being evaluated in the AZURE Phase 3 registrational...

13 Dec

Posted at 20:38h in by

/ PORTFOLIO San Diego, CABiolinq is a medical device company developing a wearable biosensor platform that measures biomarkers important to the management of many clinical conditions including diabetes. The company's first product is a needle-free, intelligent continuous glucose monitoring system.BIOLINQ.COM © Copyright RiverVest® All Rights Reserved....